"La IPS CENTRO CIENTIFICO ASITENCIAL S.A.S ofrece servicios de salud de baja y mediana complejidad, orientados al fomento de la salud, la prevención primaria y secundaria, tratamiento y seguimiento de enfermedades crónicas no transmisibles, en el contexto de la conducción de estudios clínicos, bajo el rigor de los preceptos éticos y científicos de las Buenas Prácticas Clínicas."

During the past decade, IPS Centro Cientifico Asistencial S.A.S conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "IPS Centro Cientifico Asistencial S.A.S" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "IPS Centro Cientifico Asistencial S.A.S" are "Heart Failure" (2 trials), "Atrial Fibrillation" (1 trials), "Chronic Heart Failure With Preserved Ejection Fraction" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "IPS Centro Cientifico Asistencial S.A.S" in a lesser frequency.

Most popular intervention types in "IPS Centro Cientifico Asistencial S.A.S" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials) and "Asundexian matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "IPS Centro Cientifico Asistencial S.A.S" are 5 trials for "All" genders.

Currently, there are NaN active trials in "IPS Centro Cientifico Asistencial S.A.S". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in IPS Centro Cientifico Asistencial S.A.S, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in IPS Centro Cientifico Asistencial S.A.S, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".